Harrow (NASDAQ:HROW) executives used the company’s fourth-quarter 2025 earnings call to highlight what CEO Mark Baum ...
Investor's Business Daily on MSN
Why IBD stock of the day Harrow has its sights on a breakout
Harrow is Monday's IBD Stock Of The Day. The biotech stock is setting up to tack a handle onto a seven-week cup.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results